A Post-Marketing Observational Study of VYXEOS™

NCT03526926 · clinicaltrials.gov ↗

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Therapy-Related Acute Myeloid Leukemia

Interventions

DRUG: CPX-351

Sponsor

Jazz Pharmaceuticals